Multiparametric Magnetic Resonance Imaging of the Prostate: Current Status in Prostate Cancer Detection, Localization, and Staging

Seminars in Roentgenology

Volumn 43, Issue 4, 2008, Pages 303-313

  Macura, Katarzyna J ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER STAGING; CRYOABLATION; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; TRANSRECTAL ULTRASONOGRAPHY;

BIOPSY; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEOPLASM STAGING; PROSTATE; PROSTATIC NEOPLASMS;

EID: 50549083376     PISSN: 0037198X     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ro.2008.06.002     Document Type: Article

References (95)

1. American Cancer Society. Cancer facts and figures 2007. Publication no. 500807 (2006), American Cancer Society, Atlanta, GA
2. Okotie O.T., Roehl K.A., Han M., et al. Characteristics of prostate cancer detected by digital rectal examination only. Urology 70 6 (2007) 1117-1120
3. Smith D.S., and Catalona W.J. Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology 45 (1995) 70-74
4. Karakiewicz P.I., Benayoun S., Kattan W.M., et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 173 (2005) 1930-1934
5. Bozeman C.B., Carver B.S., Caldito G., et al. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL. Urology 66 (2005) 803-807
6. Bosch J.L., Bohnen A.M., and Groeneveld F.P. Validity of digital rectal examination and serum prostate specific antigen in the estimation of prostate volume in community-based men aged 50 to 78 years: the Krimpen Study. Eur Urol 46 (2004) 753-759
7. Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324 (1991) 1156-1161
8. Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter. N Engl J Med 350 22 (2004) 2239-2246
9. Mettlin C. Preliminary findings from the American Cancer Society National Prostate Cancer Detection Project. Proceedings of the 5th International Symposium on Transrectal Ultrasound in the Diagnosis and Management of Prostate Cancer, September 14. Chicago, IL (1990) 84-85
10. Levine M.A., Ittman M., Melamed J., et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159 (1998) 471-476
11. Steven D., McCabe K., Peretsman S., et al. Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer. J Urol 159 (1998) 1606-1608
12. Byar D.P., and Mostofi F.K. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer 30 1 (1972) 5-13
13. Obek C., Louis P., Civantos F., et al. Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol 161 (1999) 494
14. Salomon L., Colombel M., Patard J.J., et al. Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping. Eur Urol 35 (1999) 289
15. Hricak H., Williams R.D., Spring D.B., et al. Anatomy and pathology of the male pelvis by magnetic resonance imaging. AJR Am J Roentgenol 141 (1983) 1101-1110
16. Bezzi M., Kressel H.Y., Allen K.S., et al. Prostatic carcinoma: staging with MR imaging at 1.5T. Radiology 168 (1988) 339-346
17. Hricak H., Choyke P.L., Eberhardt S.C., et al. Imaging prostate cancer: a multidisciplinary perspective. Radiology 243 (2007) 28-53
18. Rifkin M.D., Zerhouni E.A., Gatsonis C.A., et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. New Engl J Med 323 (1990) 621-626
19. Schnall M.D., and Pollack H.M. Magnetic resonance imaging of the prostate gland. Urol Radiol 12 (1990) 109-114
20. Schiebler M.L., Yankaskas B.C., Tempany C., et al. MR imaging in adenocarcinoma of the prostate: interobserver variation and efficacy for determining stage C disease. AJR Am J Roentgenol 158 (1992) 559-562
21. Outwater E.K., Petersen R.O., Siegelman E.S., et al. Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 193 (1994) 333-339
22. Bernstein M.R., Cangiano T., D'Amico A., et al. Endorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostate. Urol Oncol 5 (2000) 104-107
23. May F., Treumann T., Dettmar P., et al. Limited value of endorectal magnetic resonance imaging and transrectal ultrasonography in the staging of clinically localized prostate cancer. BJU Int 87 (2001) 66-69
24. Cornud F., Flam T., Chauveinc L., et al. Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results. Radiology 224 (2002) 203-210
25. Mullerad M., Hricak H., Kuroiwa K., et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. J Urol 174 (2005) 2158-2163
26. Yu K.K., Hricak H., Alagappan R., et al. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR imaging: multivariate feature analysis. Radiology 202 (1997) 697-702
27. Kurhanewicz J., Vigneron D.B., Nelson S.J., et al. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology 45 (1995) 459-466
28. 3) spatial resolution. Radiology 198 (1996) 795-805
29. Koh D.M., and Padhani A.R. Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. Br J Radiol 79 (2006) 633-635
30. Noworolski S.M., Henry R.G., Vigneron D.B., et al. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI. Magn Reson Med 53 (2005) 249-255
31. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213 (1999) 473-480
32. Denis L.J., Murphy G.P., and Schroeder F.H. Report of the consensus workshop on screening and global strategy for prostate cancer. Cancer 75 (1995) 1187-1207
33. Coakley F.V., Qayyum A., and Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. J Urol 170 (2003) S69-S75
34. Westphalen A.C., Coakley F.V., Qayyum A., et al. Peripheral zone prostate cancer: accuracy of different interpretive approaches with MR and MR spectroscopic imaging. Radiology 246 (2007) 177-184
35. Liney G.P., Turnbull L.W., and Knowles A.J. In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland. NMR Biomed 12 (1999) 39-44
36. Kurhanewicz J., Swanson M.G., Nelson S.J., et al. Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 16 (2002) 451-463
37. Shukla-Dave A., Hricak H., Moskowitz C., et al. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. Radiology 245 (2007) 499-506
38. Males R.G., Vigneron D.B., Star-Lack J., et al. Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn Reson Med 43 (2000) 17-22
39. Zakian K.L., Eberhardt S., Hricak H., et al. Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging-initial results. Radiology 229 (2003) 241-247
40. Wefer A.E., Hricak H., Vigneron D.B., et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164 (2000) 400-404
41. Hasumi M., Suzuki K., Taketomi A., et al. The combination of multivoxel MR spectroscopy with MR imaging improve the diagnostic accuracy for localization of prostate cancer. Anticancer Res 23 (2003) 4223-4227
42. Portalez D., Malavaud B., Herigault G., et al. Predicting prostate cancer with dynamic endorectal coil MR and proton spectroscopic MR imaging. J Radiol 85 (2004) 1999-2004
43. Squillaci E., Manenti G., Mancino S., et al. MR spectroscopy of prostate cancer. Initial clinical experience. J Exp Clin Cancer Res 24 (2005) 523-530
44. Vilanova J.C., and Barcelo J. Prostate cancer detection: MR spectroscopic imaging. Abdom Imaging 32 (2007) 253-261
45. Yu K.K., Scheidler J., Hricak H., et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213 (1999) 481-488
46. Wang L., Hricak H., Kattan M.W., et al. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 238 (2006) 597-603
47. Kurhanewicz J., Vigneron D.B., Males R.G., et al. The prostate: MR imaging and spectroscopy. Present and future. Radiol Clin North Am 38 (2000) 115-138
48. Zakian K.L., Sircar K., Hricak H., et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234 (2005) 804-814
49. Prando A, Billis A: Focal prostatic atrophy: mimicry of prostatic cancer on TRUS and 3D-MRSI studies. Abdom Imaging: printed online March 4, 2008
50. Qayyum A., Coakley F.V., Lu Y., et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol 183 (2004) 1079-1083
51. Kaji Y., Kurhanewicz J., Hricak H., et al. Localizing prostate cancer in the presence of post-biopsy change on MR images: role of proton MR spectroscopic imaging. Radiology 206 (1998) 785-790
52. Tien R.D., Felsberg G.J., Friedman H., et al. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 162 (1994) 671-677
53. Sugahara T., Korogi Y., Kochi M., et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9 (1999) 53-60
54. Castillo M., Smith J.K., Kwock L., et al. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradial 22 (2001) 60-64
55. Desouza N.M., Reinsberg S.A., Scurr E.D., et al. Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol 80 (2007) 90-95
56. Gibbs P., Tozer D.J., Liney G.P., et al. Comparison of quantitative T2 mapping and diffusion-weighted imaging in the normal and pathologic prostate. Magn Reson Med 46 (2001) 1054-1058
57. Bashar I. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo-planar imaging. J Magn Reson Imaging 16 (2002) 196-200
58. Hosseinzadeh K., and Schwarz S.D. Endorectal diffusion-weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging 20 (2004) 654-661
59. Kozlowski P., Chang S.D., Jones E.C., et al. Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis-correlation with biopsy and histopathology. J Magn Reson Imaging 24 (2006) 108-113
60. Kozlowski P., Chang S.D., and Goldenberg S.L. Diffusion-weighted MRI in prostate cancer-comparison between single-shot fast spin echo and echo planar imaging sequences. Magn Reson Imaging 26 (2008) 72-76
61. Ichikawa T., Haradome H., Hachiya J., et al. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 170 (1998) 397-402
62. Ichikawa T., Haradome H., Hachiya J., et al. Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging 24 (1999) 456-461
63. Haider M.A., Kwast T.H., Tanguay J., et al. Combined T2-weighted and diffusion weighted MRI for Localization of prostate cancer. AJR Am J Roentgenol 189 (2007) 323-328
64. DeSouza N., Riches S., vanAs N., et al. Potential value of diffusion weighted imaging as an indicator of tumor aggressiveness in prostate cancer. Proceedings of the International Society of Magnetic Resonance in Medicine 15, May 19-25. Berlin (2007) 3659
65. DeSouza N.M., Gilderdale D.J., Puni R., et al. A solid reusable endorectal receiver coil for magnetic resonance imaging of the prostate: design, use, and comparison with an inflatable endorectal coil. J Magn Reson Imaging 6 (1996) 801-804
66. Rosen Y., Bloch B.N., Lenkinski R.E., et al. 3T MR of the prostate: reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension. Magn Reson Med 57 (2007) 898-904
67. Brown G., Macvicar D.A., Ayton V., et al. The role of intravenous contrast enhancement in magnetic resonance imaging of prostatic carcinoma. Clin Radiol 50 (1995) 601-606
68. Liney G.P., Turnbull L.W., and Knowles A.J. In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland. NMR Biomed 12 (1999) 39-44
69. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 203 (1997) 645-652
70. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 166 (1996) 845-852
71. Barentsz J.O., Engelbrecht M., Jager G.J., et al. Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer. J Magn Reson Imaging 10 (1999) 295-304
72. Namimoto T., Morishita S., Saitoh R., et al. The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate. Comput Med Imaging Graph 22 (1998) 239-245
73. Padhani A.R., Gapinski C.J., Macvicar D.A., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55 (2000) 99-109
74. Padhani A.R., Hayes C., Landau S., et al. Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 15 (2002) 143-153
75. Engelbrecht M.R., Huisman H.J., Laheij R.J., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229 (2003) 248-254
76. Buckley D.L., Roberts C., Parker G.J., et al. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging-initial experience. Radiology 233 (2004) 709-715
77. Alonzi R., Padhani A.R., and Allen C. Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 63 (2007) 335-350
78. Kurhanewicz J., Vigneron D., Carroll P., et al. Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol 18 (2008) 71-77
79. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
80. Tofts P.S. Modeling tracer kinetics in dynamic Gd-D TPA MR imaging. J Magn Reson Imaging 7 (1997) 91-101
81. Hara N., Okuizumi M., Koike H., et al. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 62 (2005) 140-147
82. Fütterer J.J., Engelbrecht M.R., Huisman H.J., et al. Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers. Radiology 237 (2005) 541-549
83. Reinsberg S.A., Payne G.S., Riches S.F., et al. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 188 (2007) 91-98
84. Van Dorsten F.A., Van der Graaf M., Engelbrecht M.R., et al. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging 20 (2004) 279-287
85. Noworolski S.M., Henry R.G., Vigneron D.B., et al. Dynamic contrast-enhanced MRI in normal and abnormal prostate tissue as defined by biopsy, MRI, and MRSI. Magn Reson Med 53 (2005) 249-255
86. Futterer J.J., Heijmink S.W., Scheenen T.W., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241 (2006) 449-458
87. Cornfeld D.M., and Weinreb J.C. MR imaging of the prostate: 1.5T versus 3T. Magn Reson Imaging Clin North Am 15 (2007) 433-448
88. Heijmink S.W., Fütterer J.J., Hambrock T., et al. Prostate cancer: body-array versus endorectal coil MR imaging at 3 T-comparison of image quality, localization, and staging performance. Radiology 244 (2007) 184-195
89. Fütterer J.J., Scheenen T.W., Huisman H.J., et al. Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1H-spectroscopic imaging of the prostate. Invest Radiol 39 (2004) 671-680
90. Pickles M., Gibbs P., Sreenivas M., et al. Diffusion-weighted imaging of normal and malignant prostate tissue at 3T. J Magn Reson Imaging 23 (2006) 130-134
91. Chen A., Xu D., Sotto C., et al. High resolution MRSI and DTI of prostate cancer at 3T. Proceedings of the International Society of Magnetic Resonance in Medicine 15, May 19-25. Berlin (2007) 2887
92. Hamilton G., Middelton M., Choi S., et al. Improved MR spectral analysis for a PFC-filled endo-rectal prostate surface coil compared to an air-filled coil. Proceedings of the International Society of Magnetic Resonance in Medicine 15, May 19-25. Berlin (2007) 1400
93. Scheenen T.W., Heijmink S.W., Roell S.A., et al. Three-dimensional proton MR spectroscopy of human prostate at 3 T without endorectal coil: feasibility. Radiology 245 (2007) 507-516
94. Gibbs P., Pickles M.D., and Turnbull L.W. Diffusion imaging of the prostate at 3.0 Tesla. Invest Radiol 41 (2006) 185-188
95. Fuchsjäger M., Shukla-Dave A., Akin O., et al. Prostate cancer imaging. Acta Radiol 49 (2008) 107-120